This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
ASCO 2024
ASCO 2024 Bladder Cancer
Conferences
ASCO 2024
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Upper Tract Urothelial Carcinoma
Press Releases
ASCO 2024 Bladder Cancer
Viewing 121-140 of 174 articles
#AUA14 - High throughput genetic screening with Drosophila melanogaster identifies novel genes associated with stone formation - Session Highlights
#AUA14 - Gain of chromosome 8q is associated with inferior survival in patients with renal cell carcinoma - Session Highlights
#AUA14 - Neutrophil-to-lymphocyte ratio (NLR): Prognostic indicator for overall survival (OS) in patients undergoing radical cystectomy (RC) - Session Highlights
#AUA14 - Is extended pharmacological venous thromboembolism prophylaxis uniformly safe following radical cystectomy? - Session Highlights
#AUA14 - Urinary continence after robotic prostatectomy: Results from a randomized, double-blind multi-center phase 4 clinical trial evaluating solifenacin succinate versus placebo - Session Highlights
#AUA14 - Do cystine parameters predict clinical stone activity - Session Highlights
#AUA14 - Comparison of three multi-parametric MRI scoring systems for the detection of prostate cancer on MR/TRUS fusion guided prostate biopsy - Session Highlights
#AUA14 - How useful is a negative preoperative urine dipstick analysis in predicting sepsis after percutaneous nephrolithotomy? - Session Highlights
#AUA14 - Pioneering ambulatory PCNL: The Canadian experience - Session Highlights
#AUA14 - Comparative analysis of stone composition and stone culture after percutaneous nephrolithotomy - Session Highlights
#AUA14 - Poster: Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma
#AUA14 - Poster: How safe is extended pharmacological venous thromboembolism prophylaxis (EPVTEP) following radical cystectomy?
#AUA14 - Progress towards a practical protocol to minimize renal injury in extracorporeal shock wave lithotripsy - Session Highlights
#AUA14 - Augmented reality video simulation for robotic partial nephrectomy surgery training –- the next generation - Session Highlights
#AUA14 - Effect of post-call fatigue measured by robotic skills simulator - Session Highlights
#AUA14 - Simulating friction-force interaction between endoscopic instrumentation and the ureter - Session Highlights
#AUA14 - Does combination therapy with tamsulosin and tolterodine improve ureteral stent discomfort compared to monotherapy with tamsulosin? - a randomized controlled trial - Session Highlights
#AUA14 - Prostate cancer partner perspective -- unmet needs - Session Highlights
#AUA14 - Correlation between CT density, biochemical structure and microcomposition of urinary stones - Session Highlights
#AUA14 - In vitro results of robotic cystoscope and 3D panorama for automated bladder surveillance system (ABSS) - Session Highlights
1
2
3
4
5
6
7
8
9
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free